Search results
MKSI Gets SBTi Approval for 2030 Science-Based Emission Targets
MKS MKSI shares have surged 148.1% in the past year, outperforming the Zacks Computer & Technology sector’s growth of 31.9%. The surge can be attributed mainly to strong revenue and profit growth
Wall Street Analysts See a 48% Upside in DAVE INC (DAVE): Can the Stock Really Move This High?
Dave Inc. (DAVE) closed the last trading session at $212.02, gaining 19.6% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall
Wall Street Analysts See a 41.11% Upside in Tactile Systems Technology (TCMD): Can the Stock Really Move This High?
Tactile Systems Technology (TCMD) closed the last trading session at $26.93, gaining 1.8% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets
Can Anterix (ATEX) Climb 49.46% to Reach the Level Wall Street Analysts Expect?
Anterix (ATEX) closed the last trading session at $37.02, gaining 16.1% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street
Can TWFG, Inc. (TWFG) Climb 50.13% to Reach the Level Wall Street Analysts Expect?
TWFG, Inc. (TWFG) closed the last trading session at $19.79, gaining 7.8% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall
Does Ooma (OOMA) Have the Potential to Rally 34.21% as Wall Street Analysts Expect?
Ooma (OOMA) closed the last trading session at $13.68, gaining 17.5% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street
Wall Street Analysts Believe Omada Health, Inc. (OMDA) Could Rally 59.53%: Here's is How to Trade
Omada Health, Inc. (OMDA) closed the last trading session at $14.53, gaining 28.5% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by
Wall Street Analysts See a 77.28% Upside in Nektar (NKTR): Can the Stock Really Move This High?
Nektar Therapeutics (NKTR) closed the last trading session at $73.25, gaining 2.7% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by
Wall Street Analysts See a 47.46% Upside in Guidewire Software (GWRE): Can the Stock Really Move This High?
Guidewire Software (GWRE) closed the last trading session at $160.57, gaining 26.4% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by
Wall Street Analysts See a 33.1% Upside in SentinelOne (S): Can the Stock Really Move This High?
SentinelOne (S) closed the last trading session at $14.29, gaining 3% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street
Wall Street Analysts Believe vTv Therapeutics (VTVT) Could Rally 39.86%: Here's is How to Trade
vTv Therapeutics (VTVT) closed the last trading session at $38.13, gaining 12.6% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by
Wall Street Analysts See a 27.62% Upside in Afya (AFYA): Can the Stock Really Move This High?
Afya (AFYA) closed the last trading session at $14.3, gaining 1.6% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street
Is CALX Stock Fairly Valued? A Neutral View and $56 Target
Calix Inc. CALX is in the middle of a transition that is meant to lift software content, improve margin consistency, and expand monetization through agentic AI. That shift makes valuation more
Is Resmed Stock the Right Pick for Your Portfolio Now?
Resmed Inc. RMD keeps expanding its mask portfolio through product innovation and targeted initiatives to drive mask resupply. The company is gaining from the global supply of AirSense10 and
CTMX Stock Rallies on Strong Phase I Colorectal Cancer Study Data
Shares of CytomX Therapeutics CTMX soared 44.2% on Monday after the company reported positive phase I expansion data for its EpCAM-targeting PROBODY ADC, varsetatug masetecan (Varseta-M), in
AIG Expands Specialty Reach With McGill Tie-Up, Targets $1.6B Book
American International Group, Inc. AIG recently entered into a long-term strategic partnership with McGill and Partners. The goal is to modernize specialty insurance using data and digital tools
Wall Street Analysts Believe Alarm.com (ALRM) Could Rally 25.68%: Here's is How to Trade
Alarm.com Holdings (ALRM) closed the last trading session at $46.15, gaining 1.6% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by
Does Workiva (WK) Have the Potential to Rally 44.86% as Wall Street Analysts Expect?
Shares of Workiva (WK) have gained 6.5% over the past four weeks to close the last trading session at $61.75, but there could still be a solid upside left in the stock if short-term price targets of
Does Stagwell (STGW) Have the Potential to Rally 33.61% as Wall Street Analysts Expect?
Shares of Stagwell (STGW) have gained 28.1% over the past four weeks to close the last trading session at $6.07, but there could still be a solid upside left in the stock if short-term price targets
Wall Street Analysts See a 35.35% Upside in Liquidia Corporation (LQDA): Can the Stock Really Move This High?
Liquidia Corporation (LQDA) closed the last trading session at $36.86, gaining 8.9% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by